Cleared Special

K133305 - RHYTHM VIEW WORKSTATION

K133305 is an FDA 510(k) clearance for RHYTHM VIEW WORKSTATION, manufactured by Topera, Inc.. The device is a Class 2 Cardiovascular device with product code DQK cleared through the Special 510(k) pathway after a 49-day FDA review.

K133305 · Topera, Inc. · Cardiovascular device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Dec 2013
Decision
49d
Days
Class 2
Risk

K133305 is an FDA 510(k) clearance for the RHYTHM VIEW WORKSTATION. Classified as Computer, Diagnostic, Programmable (product code DQK), Class II - Special Controls.

Submitted by Topera, Inc. (St.Louis, US). The FDA issued a Cleared decision on December 16, 2013 after a review of 49 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1425 - the FDA cardiovascular device oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

FDA 510(k) Submission Details - K133305

510(k) Number K133305 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 28, 2013
Decision Date December 16, 2013
Days to Decision 49 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
76d faster than avg
Panel avg: 125d · This submission: 49d
Pathway characteristics
Modification to existing cleared device.

DQK Device Classification - Class 2, Special Controls

Product Code DQK Computer, Diagnostic, Programmable
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1425
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQK Computer, Diagnostic, Programmable

All 414
Devices cleared under the same product code (DQK) and FDA review panel - the closest regulatory comparables to K133305.
MCKESSON CARDIOLOGY ECG MOBILE
K133534 · Mckesson Israel , Ltd. · Apr 2014
EP-TRACER SYSTEM, EP-TRACER SYSTEM, EP-TRACER SYSTEM
K134044 · Cardio Tek, BV · Mar 2014
CARTO3 EP NAVIGATION SYSTEM, VERSION 3.2
K132782 · Biosense Webster, Inc. · Jan 2014
MARS HOLTER ANALYSIS WORKSTATION
K132437 · Ge Medical Systems Information Technologies, Inc. · Dec 2013
EP-WORKMATE, EP-NURSEMATE, EP-NURSEMATE WITH PHYSIO MODULE
K132073 · St Jude Medical · Sep 2013
ENSITE VELOCITY SYSTEM
K130727 · St Jude Medical · Aug 2013